The Cane Corso is a large Italian mastiff breed — males typically 100–120 lbs, females 90–110 lbs — with a deep chest, heavy musculature, and a relatively short lifespan typical of giant breeds (9–12 years). The breed's size is its primary health determinant: giant-breed skeletal development, GDV risk from thoracic depth, and cardiac demands from a large body mass all follow from the phenotype. Understanding these conditions and the supplement timeline appropriate for a giant breed distinguishes reactive from preventive care.

Hip and Elbow Dysplasia

Hip dysplasia in Cane Corsos occurs at rates comparable to other giant breeds — OFA statistics show approximately 40% of Cane Corsos tested have some degree of hip dysplasia, with roughly 15% graded fair and a significant minority graded mild-to-severe. Elbow dysplasia (fragmented coronoid process, osteochondrosis dissecans, ununited anconeal process) is similarly prevalent. The pathophysiology in giant breeds involves rapid growth outpacing bone remodeling capacity, producing joint incongruence during the skeletal development window (4–18 months) when dietary calcium excess, overfeeding, and excessive high-impact exercise are most damaging.

Joint supplementation in Cane Corsos must begin earlier than the clinical presentation of arthritis — cartilage damage is silent until significant loss has occurred. The recommendation for giant breeds with known dysplasia risk: begin joint supplementation at 12 months (post-growth-plate closure) and continue lifelong. Glucosamine supports cartilage matrix synthesis (aggrecan, type II collagen). Chondroitin inhibits degradative enzymes (MMP-3, aggrecanase). MSM provides anti-inflammatory and antioxidant support to synovial tissue. At giant-breed doses: glucosamine 1,500–2,000mg daily, chondroitin 800–1,200mg daily, MSM 2,000–2,500mg daily for a 100+ lb dog.

Gastric Dilatation-Volvulus (GDV)

GDV — bloat with gastric torsion — is a life-threatening emergency disproportionately affecting deep-chested breeds. The Cane Corso's thoracic depth-to-width ratio places it in the elevated-risk category alongside Great Danes, Standard Poodles, Weimaraners, and Irish Setters. In GDV, the stomach dilates with gas and rotates on its mesenteric axis, trapping contents, obstructing venous return, and rapidly progressing to cardiovascular shock, gastric necrosis, and death without emergency surgery. Mortality even with prompt surgical intervention is 10–30%.

Supplement context for GDV: no supplement prevents GDV, but several management factors reduce risk — feeding two or more meals daily rather than once daily, restricting vigorous exercise for one hour post-feeding, and avoiding large water boluses immediately post-exercise. Probiotic supplementation is relevant for general gut health and motility, though evidence specific to GDV prevention is not established. Prophylactic gastropexy (surgical stomach tacking) is the only intervention with demonstrated GDV prevention efficacy and is increasingly recommended for at-risk breeds at the time of spay/neuter.

Dilated Cardiomyopathy

Dilated cardiomyopathy (DCM) affects Cane Corsos at elevated rates relative to the general dog population — a function of both large-breed cardiac physiology and breed-specific genetic predisposition. DCM involves progressive dilation of the left ventricle with loss of systolic contractile function, reduced ejection fraction, and eventual congestive heart failure (pulmonary edema, pleural effusion). The preclinical phase (echocardiographic DCM without clinical signs) may persist for years before decompensation. Annual echocardiographic screening is appropriate for this breed from 4 years onward.

The ACVIM consensus statement on DCM recommends omega-3 fatty acids (EPA+DHA) as adjunct therapy for dogs with confirmed cardiac disease — the mechanism involves reduced inflammatory cytokine production (TNF-α, IL-1β), reduced cardiac cachexia, antiarrhythmic effects (EPA reduces ventricular ectopy), and cardiac muscle cell membrane support via DHA. Taurine deficiency has been implicated in DCM in some large breeds and grain-free-diet-fed dogs; taurine supplementation is appropriate when deficiency is suspected or confirmed (plasma taurine levels can be measured). CoQ10 supports mitochondrial function in cardiac muscle, which has the highest mitochondrial density of any tissue — see the dedicated CoQ10 guide for dosing.

Entropion and Ectropion

Eyelid conformation abnormalities are extremely common in the Cane Corso — the breed standard itself describes loose, pendulous lower eyelids, and both entropion (inward rolling of the eyelid, causing the lash line to contact the cornea) and ectropion (outward rolling, exposing the palpebral conjunctiva) occur at high rates, often in combination ("diamond eye"). Entropion causes constant corneal irritation, chronic keratitis, secondary ulceration, and pigmentary keratopathy with vision loss if untreated. Ectropion allows environmental debris and pathogens to accumulate in the conjunctival sac, causing chronic conjunctivitis.

Eyelid conformation is structural — surgical correction (blepharoplasty) is the definitive treatment for clinically significant entropion/ectropion. Supplement support for ocular surface health: DHA (the dominant phospholipid of corneal cell membranes), omega-3 support of the meibomian gland tear film lipid layer, and vitamin A for corneal epithelial differentiation. These are supportive, not corrective.

Idiopathic Epilepsy

Idiopathic epilepsy occurs in Cane Corsos at elevated breed rates — onset typically 1–5 years. "Idiopathic" denotes epilepsy without identifiable structural brain lesion (i.e., genetic/functional origin), diagnosed by exclusion of metabolic, toxic, and structural causes. Management is pharmacological (phenobarbital, potassium bromide, levetiracetam). Supplement adjuncts — MCT oil, DHA — are discussed in the dedicated epilepsy supplement guide.

The Cane Corso supplement protocol

• Joint support (glucosamine + chondroitin + MSM) — highest structural priority; giant-breed doses; begin at 12 months and continue lifelong; do not wait for clinical lameness
• Omega-3 (EPA+DHA) — cardiac support at therapeutic dose (~40mg/lb daily), anti-inflammatory for joints, DHA for ocular surface; critical for dogs with confirmed DCM
• Taurine — relevant for DCM-affected or at-risk dogs, particularly those on grain-free diets; plasma taurine testing before supplementation is ideal
• Probiotics — general gut health; GI motility support; immune calibration

Giant-breed note: all dose calculations must be based on actual body weight. A 110-lb Cane Corso requires approximately 2.5–3× the supplement dose appropriate for a 40-lb dog. Products marketed as "large breed" may still underdose a giant-breed dog.

Related: joint supplement guide · heart health guide · omega-3 guide · glucosamine complete guide · CoQ10 guide.